Published in J Clin Endocrinol Metab on May 24, 2013
Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes. PLoS One (2014) 0.94
A novel dual AMPK activator/mTOR inhibitor inhibits thyroid cancer cell growth. J Clin Endocrinol Metab (2015) 0.80
Effect of metformin on progression of head and neck cancers, occurrence of second primary cancers, and cause-specific survival. Oncologist (2015) 0.79
Metformin Is Associated with a Favorable Outcome in Diabetic Patients with Cervical Lymph Node Metastasis of Differentiated Thyroid Cancer. Eur Thyroid J (2015) 0.78
mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib. Oncotarget (2015) 0.78
Metformin blocks progression of obesity-activated thyroid cancer in a mouse model. Oncotarget (2016) 0.77
Multicompartment metabolism in papillary thyroid cancer. Laryngoscope (2015) 0.77
TMP21 modulates cell growth in papillary thyroid cancer cells by inducing autophagy through activation of the AMPK/mTOR pathway. Int J Clin Exp Pathol (2015) 0.76
Diabetes, Diabetes Treatment, and Risk of Thyroid Cancer. J Clin Endocrinol Metab (2016) 0.76
No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study. BMC Cancer (2015) 0.76
Effect of Metformin on Different Non-Diabetes Related Conditions, a Special Focus on Malignant Conditions: Review of Literature. J Clin Med Res (2017) 0.75
Perspectives of the AMP-activated kinase (AMPK) signalling pathway in thyroid cancer. Biosci Rep (2014) 0.75
Effect of Interferon-γ on the Basal and the TNFα-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement Or the BRAF V600e Mutation. Mediators Inflamm (2016) 0.75
Potential Role of Metabolic Intervention in the Management of Advanced Differentiated Thyroid Cancer. Front Oncol (2017) 0.75
The role of mTOR signaling pathway on cognitive functions in cerebral ischemia-reperfusion. Exp Ther Med (2017) 0.75
Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA (2004) 8.12
CLIP: a method for identifying protein-RNA interaction sites in living cells. Methods (2005) 6.26
Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Ann Emerg Med (2010) 3.44
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA (2008) 3.16
Effects of age, parity, and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol (2014) 2.98
Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. J Clin Endocrinol Metab (2008) 2.89
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid (2014) 2.77
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid (2012) 2.71
Thyroid Nodules. N Engl J Med (2015) 2.65
Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ (2004) 2.46
The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer. Thyroid (2009) 2.35
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET. J Nucl Med (2012) 2.08
Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial. J Am Coll Cardiol (2008) 1.91
Associations of processed meat and unprocessed red meat intake with incident diabetes: the Strong Heart Family Study. Am J Clin Nutr (2012) 1.88
Acute bacterial suppurative thyroiditis: a clinical review and expert opinion. Thyroid (2010) 1.65
Salivary gland protection with sialagogues: a case study. Thyroid (2009) 1.56
Anaplastic thyroid cancer. Endocrinol Metab Clin North Am (2008) 1.54
A 2011 survey of clinical practice patterns in the management of Graves' disease. J Clin Endocrinol Metab (2012) 1.43
Subclinical hyperthyroidism: controversies in management. Am Fam Physician (2002) 1.42
Combined levotriiodothyronine and levothyroxine therapy for hypothyroidism: are we a step closer to the magic formula? Thyroid (2004) 1.41
Levothyroxine therapy for hypothyroidism: should we abandon conservative dosage titration? Arch Intern Med (2005) 1.39
Spirituality: What do we mean? Int J Palliat Nurs (2009) 1.39
The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am (2007) 1.28
Changes in brain anatomy in focal hand dystonia. Ann Neurol (2004) 1.26
Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab (2002) 1.24
Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10. Blood (2012) 1.21
Clinical review: Ectopic cervical thyroid carcinoma--review of the literature with illustrative case series. J Clin Endocrinol Metab (2011) 1.21
The calcitonin conundrum--is it time for routine measurement of serum calcitonin in patients with thyroid nodules? J Clin Endocrinol Metab (2004) 1.20
Interactions between cognition and emotion during response inhibition. Emotion (2011) 1.18
Akt1 contains a functional leucine-rich nuclear export sequence. Biochem Biophys Res Commun (2005) 1.15
Hypothyroidism. Endocrinol Metab Clin North Am (2007) 1.14
Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study. Gut Microbes (2015) 1.12
Myxedema coma. J Intensive Care Med (2007) 1.12
Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid (2007) 1.11
Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? J Clin Endocrinol Metab (2012) 1.08
Primary thyroid lymphoma: a clinical review. J Clin Endocrinol Metab (2013) 1.08
Group interpersonal psychotherapy for low-income women with posttraumatic stress disorder. Psychother Res (2008) 1.08
Thyroid emergencies. Med Clin North Am (2012) 1.08
The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. Thyroid (2009) 1.07
Negative emotion impairs conflict-driven executive control. Front Psychol (2011) 1.05
Treatment with thyroid hormone. Endocr Rev (2014) 1.05
THE SYNERGY TO ENABLE GLYCEMIC CONTROL FOLLOWING EMERGENCY DEPARTMENT DISCHARGE PROGRAM FOR ADULTS WITH TYPE 2 DIABETES: STEP-DIABETES. Endocr Pract (2015) 1.04
Dietary patterns are linked to cardiovascular risk factors but not to inflammatory markers in Alaska Eskimos. J Nutr (2009) 1.04
Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function. Thyroid (2010) 1.03
PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDY. J Clin Lipidol (2009) 1.02
Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy. Otolaryngol Head Neck Surg (2005) 1.02
Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission? Clin Endocrinol (Oxf) (2011) 1.01
Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice. Thyroid (2002) 1.00
Standardization of hormonal assays for the 21st century. J Clin Endocrinol Metab (2010) 0.99
Radioiodine in the treatment of thyroid cancer. Endocrinol Metab Clin North Am (2007) 0.99
Threat of bodily harm has opposing effects on cognition. Emotion (2011) 0.98
KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity. J Clin Endocrinol Metab (2005) 0.98
Physical activity and neural correlates of aging: a combined TMS/fMRI study. Behav Brain Res (2011) 0.98
Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism. J Clin Endocrinol Metab (2005) 0.98
Perioperative management of patients with hypothyroidism. Endocrinol Metab Clin North Am (2003) 0.97
Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. Endocr Relat Cancer (2012) 0.96
Systemic administration of vascular endothelial growth factor monoclonal antibody reduces the growth of papillary thyroid carcinoma in a nude mouse model. Ann Clin Lab Sci (2003) 0.95
17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels. J Clin Endocrinol Metab (2004) 0.95
Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma. Thyroid (2002) 0.93
Improving patient-provider communication: a call to action. J Nurs Adm (2009) 0.93
Estimated GFR and incident cardiovascular disease events in American Indians: the Strong Heart Study. Am J Kidney Dis (2012) 0.92
Controversies surrounding pregnancy, maternal thyroid status, and fetal outcome. Thyroid (2009) 0.92
Relationship between glycemic control and depression among American Indians in the Strong Heart Study. J Diabetes Complications (2009) 0.92
Takotsubo cardiomyopathy associated with thyrotoxicosis: a case report and review of the literature. Thyroid (2013) 0.91
Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells. Mol Carcinog (2004) 0.90
Radioiodine therapy for thyroid cancer and hyperthyroidism in patients with end-stage renal disease on hemodialysis. Thyroid (2005) 0.90
Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin. Thyroid (2012) 0.90
Optimal thyrotropin level: normal ranges and reference intervals are not equivalent. Thyroid (2005) 0.90
Metastases of well-differentiated thyroid cancer to the gastrointestinal system. Thyroid (2010) 0.89
Asking well-built questions for evidence-based practice in augmentative and alternative communication. J Commun Disord (2006) 0.89
Age and the thyrotropin response to hypothyroxinemia. J Clin Endocrinol Metab (2010) 0.89
The utility of intraoperative blood flow measurement during aneurysm surgery using an ultrasonic perivascular flow probe. Neurosurgery (2008) 0.89
Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes. Cancer Chemother Pharmacol (2005) 0.89
BRAF mutations are uncommon in papillary thyroid cancer of young patients. Thyroid (2005) 0.89
Protein kinase A-independent inhibition of proliferation and induction of apoptosis in human thyroid cancer cells by 8-Cl-adenosine. J Clin Endocrinol Metab (2007) 0.89
Trauma, Depression, and Comorbid PTSD/Depression in a Community Sample of Latina Immigrants. Psychol Trauma (2010) 0.88
Thyroid disorders in pregnancy. Endocrinol Metab Clin North Am (2011) 0.87
Prevalence of immune disease in patients with wounds presenting to a tertiary wound healing centre. Int Wound J (2011) 0.87
GABA receptor expression in benign and malignant thyroid tumors. Pathol Oncol Res (2009) 0.87
Spinal metastases due to thyroid carcinoma: an analysis of 202 patients. Thyroid (2014) 0.86